Product NDC: | 39822-4000 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | levetiracetam |
Active Ingredient(s): | 100 mg/mL & nbsp; levetiracetam |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 39822-4000 |
Labeler Name: | X-GEN Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091485 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110831 |
Package NDC: | 39822-4000-1 |
Package Description: | 5 mL in 1 VIAL (39822-4000-1) |
NDC Code | 39822-4000-1 |
Proprietary Name | Levetiracetam |
Package Description | 5 mL in 1 VIAL (39822-4000-1) |
Product NDC | 39822-4000 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levetiracetam |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110831 |
Marketing Category Name | ANDA |
Labeler Name | X-GEN Pharmaceuticals, Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |